Earnings History Data for Syros Pharmaceuticals, Inc. (SYRS) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on treatments for cancer and immune-mediated diseases as well as building a pipeline of gene control medicines. The company's product pipeline includes SY-1425, a selective RARa agonist for genomically defined subsets of patients with relapsed or refractory acute myeloid leukemia and relapsed high-risk myelodysplastic syndrome and SY-1365, a selective CDK7 inhibitor for acute leukemia which is in preclinical stage. Syros Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
31-10-2024	PM		SYRS	Syros Pharmaceuticals, Inc.	67.83	-0.68	-0.76	-1.35	Syros Pharmaceuticals GAAP EPS of -$0.16 beats by $0.52 [10/31/2024 7:44 AM]	2.52	0.01 (0.40%)	2.57	0.06 (2.39%)	1.43 - 8.17	253,687	680,000	1,886
Syros Pharmaceuticals Q3 2024 Earnings Preview [10/30/2024 3:12 PM] Syros Pharmaceuticals GAAP EPS of -$0.16 beats by $0.52 [10/31/2024 7:44 AM] Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update [2024-10-31 07:30AM]
31-07-2024	PM		SYRS	Syros Pharmaceuticals, Inc.	172.93	-0.70	-0.79	-1.30	Syros Pharmaceuticals GAAP EPS of -$0.59 beats by $0.18 [7/31/2024 7:32 AM]	6.00	-0.26 (-4.15%)	0.0	0.0 (0.00%)	2.09 - 8.17	116,355	70,000	0
Syros Pharmaceuticals Q2 2024 Earnings Preview [7/30/2024 12:47 PM] Syros Pharmaceuticals GAAP EPS of -$0.59 beats by $0.18 [7/31/2024 7:32 AM]
14-05-2024	PM		SYRS	Syros Pharmaceuticals, Inc.	131.48	-0.79	-0.89	-0.85	Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77 [5/14/2024 7:31 AM]	5.43	0.38 (7.41%)	5.20	0.14 (2.77%)	2.09 - 8.17	154,034	120,000	1,206
Syros Pharmaceuticals GAAP EPS of -$0.10 beats by $0.77 [5/14/2024 7:31 AM] Syros Pharmaceuticals Q1 2024 Earnings Preview [5/13/2024 12:10 PM]
27-03-2024	PM		SYRS	Syros Pharmaceuticals, Inc.	134.83	-1.19	-1.23	-1.28	Syros Pharmaceuticals GAAP EPS of -$2.18 misses by $1.04, revenue of $0.4M misses by $1.6M [3/27/2024 7:32 AM]	5.88	-0.37 (-5.92%)	5.59	-0.66 (-10.57%)	2.09 - 8.17	409,206	130,000	4,074
Syros Pharmaceuticals Q4 2023 Earnings Preview [3/26/2024 1:53 PM] Syros Pharmaceuticals GAAP EPS of -$2.18 misses by $1.04, revenue of $0.4M misses by $1.6M [3/27/2024 7:32 AM]
14-11-2023	PM		SYRS	Syros Pharmaceuticals, Inc.	57.99	-1.35	-1.12	-2.41	Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29, revenue of $3.76M misses by $0.18M [11/14/2023 7:32 AM]	2.72	0.03 (1.12%)	0.0	0.0 (0.00%)	2.09 - 5.67	42,823	70,000	0
Syros Pharmaceuticals Q3 2023 Earnings Preview [11/13/2023 1:29 PM] Syros Pharmaceuticals Q3 2023 Earnings Preview [11/13/2023 1:05 PM] Syros Pharmaceuticals GAAP EPS of -$1.43 misses by $0.29, revenue of $3.76M misses by $0.18M [11/14/2023 7:32 AM]
08-08-2023	PM		SYRS	Syros Pharmaceuticals, Inc.	75.17	-1.30	-1.11	-5.40	Syros Pharmaceuticals GAAP EPS of $1.30 beats by $2.43, revenue of $2.8M misses by $0.7M [8/8/2023 7:37 AM]	3.66	-0.02 (-0.54%)	3.60	-0.08 (-2.17%)	2.42 - 10.50	40,168	70,000	1,008
Syros Pharmaceuticals Q2 2023 Earnings Preview [8/7/2023 12:46 PM] Syros Pharmaceuticals GAAP EPS of $1.30 beats by $2.43, revenue of $2.8M misses by $0.7M [8/8/2023 7:37 AM]
10-05-2023	PM	7:30 AM ET (May 10)	SYRS	Syros Pharmaceuticals, Inc.	61.84	-0.85	-1.12	4.00	Syros Pharmaceuticals GAAP EPS of -$0.85 beats by $0.20, revenue of $3M misses by $0.3M [5/10/2023 7:32 AM]	3.44	0.33 (10.61%)	0.0	0.0 (0.00%)	2.42 - 11.50	220,912	70,000	0
Syros Pharmaceuticals GAAP EPS of -$0.85 beats by $0.20, revenue of $3M misses by $0.3M [5/10/2023 7:32 AM]
02-03-2023	PM	7:30 AM ET (Mar 2)	SYRS	Syros Pharmaceuticals, Inc.	79.89	-1.28	-1.27	-4.20	Syros Pharmaceuticals GAAP EPS of -$0.17 beats by $1.13 [3/2/2023 7:34 AM]	3.72	0.06 (1.64%)	3.79	0.13 (3.55%)	3.02 - 14.30	110,684	90,000	2,581
Syros Pharmaceuticals Q4 2022 Earnings Preview [3/1/2023 12:58 PM] Syros Pharmaceuticals GAAP EPS of -$0.17 beats by $1.13 [3/2/2023 7:34 AM]
14-11-2022	PM	7:30 AM ET (Nov 14)	SYRS	Syros Pharmaceuticals, Inc.	76.09	-2.41	-3.91	-4.10	Syros Pharmaceuticals GAAP EPS of -$3.21 beats by $0.30, revenue of $3.9M misses by $1.28M [11/14/2022 7:35 AM]	3.72	-0.26 (-6.53%)	4.00	0.02 (0.50%)	3.52 - 43.40	143,351	120,000	1,234
Syros Pharmaceuticals GAAP EPS of -$3.21 beats by $0.30, revenue of $3.9M misses by $1.28M [11/14/2022 7:35 AM] Syros Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides a Corporate Update [Nov-14-22 07:30AM]
09-08-2022	PM	7:30 AM ET (Aug 9)	SYRS	Syros Pharmaceuticals, Inc.	60.06	-0.54	-0.42	-0.36	Syros Pharmaceuticals GAAP EPS of -$0.54 misses by $0.13, revenue of $6.28M beats by $1.5M [8/9/2022 7:33 AM]	0.9201	-0.06 (-5.64%)	0.87	-0.10 (-10.77%)	0.65 - 5.64	919,867	1,400,000	106,980
Syros Pharmaceuticals Q2 2022 Earnings Preview [8/8/2022 2:40 PM] Syros Pharmaceuticals GAAP EPS of -$0.54 misses by $0.13, revenue of $6.28M beats by $1.5M [8/9/2022 7:33 AM] Syros Pharma stock slips after mixed Q2 results & a significant prior runup in shares [8/9/2022 3:43 PM]
16-05-2022	PM	7:30 AM ET (May 16)	SYRS	Syros Pharmaceuticals, Inc.	52.83	-0.40	-0.48	-0.23	Syros Pharmaceuticals GAAP EPS of -$0.40 beats by $0.07, revenue of $5.47M beats by $0.55M [5/16/2022 7:31 AM]	0.77	-0.13 (-14.34%)	0.93	0.03 (3.46%)	0.76 - 7.03	1,016,141	810,000	2,693
Syros Pharmaceuticals GAAP EPS of -$0.40 beats by $0.07, revenue of $5.47M beats by $0.55M [5/16/2022 7:31 AM] Strength Seen in Immatics (IMTX): Can Its 5.3% Jump Turn into More Strength? [May-13-22 08:13AM] Syros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides a Corporate Update [May-16-22 07:30AM] Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates [May-16-22 08:45AM]
15-03-2022	PM	7:30 AM ET (Mar 15)	SYRS	Syros Pharmaceuticals	76.00	-0.42	-0.44	0.00	Syros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08, revenue of $78M beats by $73.16M [3/15/2022 7:37 AM]	1.36	0.07 (5.79%)	1.16	0.09 (8.41%)	1.12 - 9.80	392,240	437,743	4,523
Syros Pharmaceuticals Q4 2021 Earnings Preview [3/14/2022 12:28 PM] Syros Pharmaceuticals GAAP EPS of -$0.38 beats by $0.08, revenue of $78M beats by $73.16M [3/15/2022 7:37 AM] Syros Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones [Mar-15-22 07:32AM] Syros Pharmaceuticals, Inc. (SYRS) Reports Q4 Loss, Tops Revenue Estimates [Mar-15-22 08:55AM]
05-11-2021	PM	7:30 AM ET (Nov 5)	SYRS	Syros Pharmaceuticals, Inc.	271.88	-0.41	-0.43	-0.43	Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [11/5/2021 7:40 AM]	4.57	0.15 (3.39%)	4.50	0.08 (1.81%)	4.00 - 15.65	480,245	310,000	1,529
Syros Pharmaceuticals Q3 2021 Earnings Preview [11/4/2021 11:09 AM] Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [11/5/2021 7:40 AM] Syros Reports Third Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones [Nov-05-21 07:30AM] Syros Pharmaceuticals, Inc. (SYRS) Reports Q3 Loss, Tops Revenue Estimates [Nov-05-21 08:55AM]
05-08-2021	PM	7:30 AM ET (Aug 5)	SYRS	Syros Pharmaceuticals, Inc.	283.31	-0.36	-0.36	-0.38	Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [8/5/2021 7:47 AM]	4.89	0.38 (8.43%)	4.70	0.19 (4.21%)	4.35 - 15.65	958,145	480,000	420,253
Syros Pharmaceuticals EPS beats by $0.03, beats on revenue [8/5/2021 7:47 AM] Syros Announces Agreement with Roche to Evaluate SY-5609 as Part of a Novel Combination for Treatment of Colorectal Cancer [Aug-05-21 07:15AM] Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones [Aug-05-21 07:30AM] Syros Pharmaceuticals, Inc. (SYRS) Reports Q2 Loss, Tops Revenue Estimates [Aug-05-21 08:55AM]
06-05-2021	PM	7:30 AM ET (May 6)	SYRS	Syros Pharmaceuticals, Inc.	348.21	-0.23	-0.55	-0.39	Syros Pharmaceuticals EPS beats by $0.24, beats on revenue [5/6/2021 7:33 AM]	5.53	0.05 (0.91%)	5.53	0.0 (0.00%)	5.07 - 15.65	789,932	550,000	6,364
Syros Pharmaceuticals EPS beats by $0.24, beats on revenue [5/6/2021 7:33 AM] Syros Reports First Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones [May-06-21 07:31AM] Syros Pharmaceuticals, Inc. (SYRS) Reports Q1 Loss, Tops Revenue Estimates [May-06-21 08:50AM]
04-03-2021	PM	7:30 AM ET (Mar 4)	SYRS	Syros Pharmaceuticals, Inc.	564.23	-0.61	-0.54	-0.46	Syros Pharmaceuticals EPS misses by $0.12, beats on revenue [3/4/2021 7:39 AM]	7.99	-0.33 (-3.97%)	8.26	-0.06 (-0.72%)	4.26 - 15.65	951,160	754,073	1,957
Syros Pharmaceuticals EPS misses by $0.12, beats on revenue [3/4/2021 7:39 AM] Looking Into Syros Pharmaceuticals's Return On Capital Employed [Mar-04-21 10:23AM] Syros Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Key Accomplishments and Upcoming Milestones [Mar-04-21 07:30AM] Syros Pharmaceuticals, Inc. to Host Earnings Call [Mar-04-21 06:30AM]
05-11-2020	AH	4:05 PM ET (Nov 5)	SYRS	Syros Pharmaceuticals, Inc.	346.88	-0.43	-0.38	-0.47	Syros Pharmaceuticals EPS misses by $0.05, beats on revenue [11/5/2020 5:49 PM]	8.45	0.34 (4.19%)	8.15	0.04 (0.49%)	4.26 - 14.69	307,218	634,624	700

06-08-2020	PM	7:30 AM ET (Aug 6)	SYRS	Syros Pharmaceuticals, Inc.	473.84	-0.38	-0.40	-0.47	Syros Pharmaceuticals EPS beats by $0.02, beats on revenue [8/6/2020 7:41 AM]	11.81	0.53 (4.70%)	11.28	0.0 (0.00%)	4.26 - 12.75	141,785	179,012	5,011